Our Collaborators
The Palavicini lab works very closely with several internal and external collaborators. Doing science in isolation hinders its potential, and we believe our collaborations bring our research to the next level.
Internal Collaborators
Dr. Hopp, together with Dr. Palavicini, co-leads the PLCG2/Alzheimer's/Aging project, funded by the Alzheimer's Association. They currently co-mentor three students and shared co-correspondence in a recent preprint.
(210) 450-8657
Drs. Griffith, Palavicini, and Hopp recently received a pilot grant entitled "Exploring the impact of PLCG2 function and risk variant mutations on T cell tolerance in late-onset Alzheimer's disease".
(210) 567-3978
Dr. Koronowski, together with Dr. Palavicini, co-leads the chronic jet lag/Alzheimer's/Aging project, funded by the William and Ella Owens Medical Research Foundation.
(210) 450-7147
The Palavicini and Goldberg labs are collaborating on a project examining how stroke influences Alzheimer’s disease-related pathologies, leveraging next-generation animal models, advanced imaging platforms, and transcriptomic profiling.
​
The Palavicini lab is collaborating with the Ruiz lab on a project investigating progranulin levels in human CSF and plasma samples, and its association with proteomic and lipidomic sigantures, as well as Alzheimer's disease-related pathologies.
​
Drs. Norton and Palavicini have been collaborating since 2020, these efforts have led to two co-authored publications and a preprint.
(210) 567-0739
Elizabeth Fernandez, PhD
Dr. Fernandez leads the Nathan Shock Center Integrated Physiology of Aging (IPA) Core. The Palavicini lab is a frequent user of multiple services that the IPA core offers.
(210) 562-6050
Mansour Zadeh, PhD
Dr. Zadeh is studying the impact of vitamin B12 deficiency in neuro-degenerative diseases. Drs. Zadeh and Palavicini have co-authored one publication and are submitting several MPI grants.
(210) 567-4880
External Collaborators
(Wake Forest University)
Dr. Orr, a "Rising star" in Alzheimer's disease and senescence, and Dr. Palavicini have been collaborating since 2020, these efforts have led to two co-authored publications and more to come.
​
Andrew Murton, PhD
(UTMB Health)
Dr. Murton and Dr. Palavicini recently received a Claude D. Pepper OAIC multi-Center pilot grant to test a ceramide-lowering drug in non-human primates.
​
Jeff Dupree, PhD
(Virginia Commonwealth University)
Dr. Dupree and Dr. Palavicini have been collaborating since 2015, these efforts have led to 7 co-authored publications and more to come.
(804) 828-9536
(Texas Biomedical Research Institute)
Dr. Ross, the new director of the Southwest National Primate Research Center, is the site PI of two separate marmoset pilot grants awarded to Dr. Palavicini.
(210) 258-9400